Literature DB >> 16877015

Enhanced oxidative cross-linking of hemoglobin E with spectrin and loss of erythrocyte membrane asymmetry in hemoglobin Ebeta-thalassemia.

Poppy Datta1, Sumanta Basu, Sudipa Basu Chakravarty, Amit Chakravarty, Debashis Banerjee, Sharmila Chandra, Abhijit Chakrabarti.   

Abstract

Oxidative stress to the erythrocytes is associated with formation of large molecular complexes of hemoglobin and the skeletal protein, spectrin. In this work, such complexes are formed with hemoglobin mixtures isolated from patients suffering from HbEbeta-thalassemia with elevated levels of the HbE and purified erythroid spectrin in the presence of hydrogen peroxide. The complexes are separated on 4% SDS-PAGE and analyzed by densitometry. The results indicate enhanced formation of complexes with higher amounts of HbE, the most common hemoglobin variant prevalent in Southeast Asia. The binding affinity of spectrin with hemoglobin, in the absence of hydrogen peroxide, was found to increase with hemoglobin mixtures enriched with HbE. The presence of ATP was also found to decrease the overall yield of such complexes. Flow cytometric measurements of phosphatidylserine on the red cell surface also showed a lower degree of membrane asymmetry in HbEbeta-thalassemic patients than in normal subjects. The present work shows enhanced formation of high molecular weight cross-linked complexes of hemoglobin derivatives with erythroid spectrin in HbEbeta-thalassemia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16877015     DOI: 10.1016/j.bcmd.2006.06.001

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  8 in total

1.  Spectrin interactions with globin chains in the presence of phosphate metabolites and hydrogen peroxide: implications for thalassaemia.

Authors:  Poppy Datta; Sudipa Chakrabarty; Amit Chakrabarty; Abhijit Chakrabarti
Journal:  J Biosci       Date:  2007-09       Impact factor: 1.826

2.  A transgenic mouse model expressing exclusively human hemoglobin E: indications of a mild oxidative stress.

Authors:  Qiuying Chen; Mary E Fabry; Anne C Rybicki; Sandra M Suzuka; Tatiana C Balazs; Zipora Etzion; Kitty de Jong; Edna K Akoto; Joseph E Canterino; Dhananjay K Kaul; Frans A Kuypers; David Lefer; Eric E Bouhassira; Rhoda Elison Hirsch
Journal:  Blood Cells Mol Dis       Date:  2012-01-18       Impact factor: 3.039

Review 3.  Leg Ulcers: A Report in Patients with Hemoglobin E Beta Thalassemia and Review of the Literature in Severe Beta Thalassemia.

Authors:  Vikita Mehta; Abirami Kirubarajan; Amir Sabouhanian; Sanasi M Jayawardena; Priya Chandrakumaran; Nila Thangavelu; Refai Cader; Sachith Mettananda; Dayananda Bandara; Shawn Khan; David J Weatherall; Angela Allen; Anuja P Premawardhena; Nancy F Olivieri
Journal:  Acta Haematol       Date:  2021-11-09       Impact factor: 3.068

4.  Do Transfusion Dependent E-Βeta Thalassemics Behave Differently from Patients with Βeta-Thalassemia Major?

Authors:  Sandip Sen; Rajat Mohapatra; Prantar Chakrabarti
Journal:  Indian J Hematol Blood Transfus       Date:  2021-02-05       Impact factor: 0.915

Review 5.  HbE/β-Thalassemia and Oxidative Stress: The Key to Pathophysiological Mechanisms and Novel Therapeutics.

Authors:  Rhoda Elison Hirsch; Nathawut Sibmooh; Suthat Fucharoen; Joel M Friedman
Journal:  Antioxid Redox Signal       Date:  2016-11-28       Impact factor: 8.401

6.  Eryptosis in hereditary spherocytosis and thalassemia: role of glycoconjugates.

Authors:  Sumanta Basu; Debasis Banerjee; Sarmila Chandra; Abhijit Chakrabarti
Journal:  Glycoconj J       Date:  2009-09-16       Impact factor: 2.916

Review 7.  Hb E/beta-thalassaemia: a common & clinically diverse disorder.

Authors:  Nancy F Olivieri; Zahra Pakbaz; Elliott Vichinsky
Journal:  Indian J Med Res       Date:  2011-10       Impact factor: 2.375

8.  Differential thermal stability and oxidative vulnerability of the hemoglobin variants, HbA2 and HbE.

Authors:  Abhijit Chakrabarti; Dipankar Bhattacharya; Sanghamitra Deb; Madhumita Chakraborty
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.